England is risking its own opioid epidemic, says PHEHundreds of thousands of people in England are at risk of dependency on prescription medicines like opioid painkillers, Share XEngland is risking its own opioid epidemic, says PHEhttps://pharmaphorum.com/news/england-is-risking-its-own-opioid-epidemic-says-phe/
Purdue preps bankruptcy as opioid settlement bid stumbles; reportPurdue Pharma is reported to be preparing to file for bankruptcy amid resistance to its $10-$12 billion offer Share XPurdue preps bankruptcy as opioid settlement bid stumbles; reporthttps://pharmaphorum.com/news/purdue-preps-bankruptcy-as-opioid-settlement-bid-stumbles-report/
NICE lowers threshold for blood pressure drugs in new guidanceNew guidelines on the management of high blood pressure in the UK will see thousands more patients eligible Share XNICE lowers threshold for blood pressure drugs in new guidancehttps://pharmaphorum.com/news/nice-lowers-threshold-for-blood-pressure-drugs-in-new-guidance/
J&J hit by $572m verdict in Oklahoma opioid caseJohnson & Johnson has been ordered to pay $572 million to remedy its part in the opioid crisis Share XJ&J hit by $572m verdict in Oklahoma opioid casehttps://pharmaphorum.com/news/jj-hit-by-572m-verdict-in-oklahoma-opioid-case/
Low-cost polypill could dramatically cut heart attacks, strokesA single tablet that contains four generically-available drugs – or ‘polypill’ – could offer an effective, low-cost way Share XLow-cost polypill could dramatically cut heart attacks, strokeshttps://pharmaphorum.com/news/low-cost-polypill-could-dramatically-cut-heart-attacks-strokes/
MSD’s Keytruda plus chemo backed by NICE for lung cancerMerck & Co/MSD’s Keytruda can be provided via the Cancer Drugs Fund for first-line treatment of non-small cell Share XMSD’s Keytruda plus chemo backed by NICE for lung cancerhttps://pharmaphorum.com/news/msds-keytruda-plus-chemo-backed-by-nice-for-lung-cancer/
Gilead’s Descovy gets FDA panel OK for PrEP, but not for womenGilead’s Descovy got a green light from an FDA advisory committee for HIV pre-exposure prophylaxis (PrEP) yesterday – Share XGilead’s Descovy gets FDA panel OK for PrEP, but not for womenhttps://pharmaphorum.com/news/gileads-descovy-gets-fda-panel-ok-for-prep-but-not-for-women/
Republican revolt threatens Senate drug pricing billA bipartisan bill voted through by the Senate Finance Committee last week is under threat from a group Share XRepublican revolt threatens Senate drug pricing billhttps://pharmaphorum.com/news/republican-revolt-threatens-senate-drug-pricing-bill/
Allergan pulls breast implants after link to rare cancerAllergan has followed through on an FDA request to carry out a worldwide recall of textured breast implant Share XAllergan pulls breast implants after link to rare cancerhttps://pharmaphorum.com/news/allergan-pulls-breast-implants-after-link-to-rare-cancer/
